Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lagier, J.-C., Armougom, F., Million, M., Hugon, P., Pagnier, I., Robert, C., Bittar, F., Fournous, G., Gimenez, G., Maraninchi, M., Trape, J.-F., Koonin, E. V., La Scola, B., & Raoult, D. (2012). Microbial culturomics: paradigm shift in the human gut microbiome study. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 18(12), 1185–1193.
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: skin of horses, seafood, cheese and human faeces
DNA G+C(%): 33.4-34.7
|
Opt. T: 30℃
High T(℃): 42(neg)
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Monosaccharide util/assim | Oligosaccharide util/assim | Other carboh. util/assim | Amino acid util/assim | Organic acid util/assim |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
penicillin_G: R(vr)
|
|
|
erythromycin: S(vr)
|
ciprofloxacin: S(MIC50): 0.25, MIC90: 0.5, RNG: (0.06->16)
gatifloxacin: S(MIC50): 0.25, MIC90: 4, RNG: (0.03->16)
levofloxacin: Var(MIC50): 0.5, MIC90: 8, RNG: (0.06->16)
moxifloxacin: S(MIC50): 0.12, MIC90: 2, RNG: (0.03->16)
trovafloxacin: S(MIC50): 0.06, MIC90: 0.4, RNG: (0.015-16)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
|
|
|
chloramphenicol: Res
|
clindamycin: S(MIC50): 0.06, MIC90: 0.5, RNG: (0.015-4)
lincomycin: S(vr)
novobiocin: R(16)
|